Search
  • Dr.Mousa

COVID-19 Booster Vaccine Recommendation

Updated: Aug 24



08/24/2021


Dear Patients,

Dr. Mousa recommends our patients get the COVID-19 booster vaccine. We are currently following the CDC (Centers for Disease Control) and the ACR (American college of Rheumatology) guidelines. They are as follows.

· It is recommended that you receive the same manufacturer booster as the previous COVID-19 vaccine you received, if possible.

· The additional vaccine should be administered at least 28 days after completion of the primary vaccine series.

· If you are taking any Rheumatology medication other than Plaquenil or Sulfasalazine it is recommended to hold your medication for 1 week AFTER the booster vaccine. You do not need to hold it prior to the vaccine.


All immunocompromised patients should continue to follow prevention measures, including:

· Wearing a mask

· Staying 6 feet apart from those they don’t live with

· Avoiding crowds and poorly ventilated indoor spaces until advised otherwise by their healthcare provider

· Close contacts of immunocompromised people should be strongly encouraged to be vaccinated against COVID-19


We will continue to follow the CDC and ACR guidelines and will update patients accordingly.


Sincerely,


Arthritis & Rheumatology of Southwest Ohio

61 views0 comments

Recent Posts

See All

COVID 19 Vaccine Information

COVID19 Vaccine Information for Patients What vaccines are currently available in the United States? There are currently 2 vaccines for COVID19 that have received emergency use authorization (EUA) by

What's in the Pfizer and Moderna Vaccines?

COVID Vaccine Ingredients There are two COVID-19 messenger-ribonucleic acid (mRNA) vaccines currently authorized for emergent use in the United States: the Pfizer-BioNTech and the Moderna vaccines. Co

COVID 19 Vaccine Information

Hi there. I am so glad that you reached out to me regarding receiving the COVID-19 vaccination. Please note that at this point in time there is not a lot of information regarding long-term side effect